OOIR: Observatory of International Research

Papers

(The H4-Index of Transfusion is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Use of convalescent plasma inCOVID‐19 patients with immunosuppression	68
Has the trend of declining blood transfusions in the United States ended? Findings of the 2019 National Blood Collection and Utilization Survey	53
SARS‐CoV‐2 seroprevalence among blood donors after the first COVID‐19 wave in Canada	50
Survey of group A plasma and low‐titer group O whole blood use in trauma resuscitation at adult civilian level 1 trauma centers in the US	46
COVID‐19 associated with severe autoimmune hemolytic anemia	44
SARS‐CoV‐2 antibody persistence in COVID‐19 convalescent plasma donors: Dependency on assay format and applicability to serosurveillance	42
Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing	41
Therapeutic plasma exchange for COVID‐19‐associated hyperviscosity	40
Production of anti‐SARS‐CoV‐2 hyperimmune globulin from convalescent plasma	39
Prehospital whole blood reduces early mortality in patients with hemorrhagic shock	39
COVID‐19 convalescent plasma: Interim recommendations from the AABB	38
HIV, HCV, and HBV incidence and residual risk in US blood donors before and after implementation of the 12‐month deferral policy for men who have sex with men	35
Blood donor obesity is associated with changes in red blood cell metabolism and susceptibility to hemolysis in cold storage and in response to osmotic and oxidative stress	33
Transition from room temperature to cold‐stored platelets for the preservation of blood inventories during the COVID‐19 pandemic	32
Transfusion‐related adverse reactions: Data from the National Healthcare Safety Network Hemovigilance Module — United States, 2013–2018	31
Severe autoimmune hemolytic anemia following receipt of SARS‐CoV‐2 mRNA vaccine	31
Extension of platelet shelf life with an improved bacterial testing algorithm	30
Fatty acid desaturase activity in mature red blood cells and implications for blood storage quality	28
Reduced sensitivity of PLASMIC and French scores for the diagnosis of thrombotic thrombocytopenic purpura in older individuals	28
Outcomes and management of immune thrombocytopenia secondary to COVID‐19: Cleveland clinic experience	27
Comparability of six different immunoassays measuring SARS‐CoV‐2 antibodies with neutralizing antibody levels in convalescent plasma: From utility to prediction	27
The impact of temporary deferrals on future blood donation behavior across the donor life cycle	27
Exponential increase in neutralizing and spike specific antibodies following vaccination of COVID‐19 convalescent plasma donors	26
A comparison of platelet function in cold‐stored whole blood and platelet concentrates	26
Injured recipients of low‐titer group O whole blood have similar clinical outcomes compared to recipients of conventional component therapy: A single‐center, retrospective study	25

Supplemental findings of the 2019 National Blood Collection and Utilization Survey	25
Cold storage of platelets in platelet additive solution maintains mitochondrial integrity by limiting initiation of apoptosis‐mediated pathways	25
Fatal sepsis associated with a storage container leak permitting platelet contamination with environmental bacteria after pathogen reduction	25
Adverse events after low titer group O whole blood versus component product transfusion in pediatric trauma patients: A propensity‐matched cohort study	25
ABO blood group and risk of COVID‐19 infection and complications: A systematic review and meta‐analysis	25